$55.4 Million is the total value of Healthcare Value Capital, LLC's 22 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 500.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPY | Buy | SPDR S&P 500 ETF TRput | $14,839,000 | +153.2% | 50,000 | +150.0% | 26.80% | +143.8% |
| VIXY | Buy | PROSHARES TR IIcall | $3,904,000 | +629.7% | 200,000 | +700.0% | 7.05% | +602.3% |
| ABBV | New | ABBVIE INC | $3,786,000 | – | 50,000 | +100.0% | 6.84% | – |
| CVS | New | CVS HEALTH CORP | $3,154,000 | – | 50,000 | +100.0% | 5.70% | – |
| WBA | New | WALGREENS BOOTS ALLIANCE INC | $2,766,000 | – | 50,000 | +100.0% | 5.00% | – |
| CAH | New | CARDINAL HEALTH INC | $1,652,000 | – | 35,000 | +100.0% | 2.98% | – |
| ABC | New | AMERISOURCEBERGEN CORP | $1,647,000 | – | 20,000 | +100.0% | 2.98% | – |
| MCK | New | MCKESSON CORP | $1,367,000 | – | 10,000 | +100.0% | 2.47% | – |
| CLVS | New | CLOVIS ONCOLOGY INC | $983,000 | – | 250,000 | +100.0% | 1.78% | – |
| FOMX | New | FOAMIX PHARMACEUTICALS LTD | $760,000 | – | 250,000 | +100.0% | 1.37% | – |
| ATRS | New | ANTARES PHARMA INC | $669,000 | – | 200,000 | +100.0% | 1.21% | – |
| FOMX | New | FOAMIX PHARMACEUTICALS LTDcall | $152,000 | – | 50,000 | +100.0% | 0.28% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-11-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GILEAD SCIENCES INC | 20 | Q3 2021 | 31.3% |
| GLAXOSMITHKLINE PLC | 20 | Q3 2021 | 16.1% |
| PFIZER INC | 19 | Q3 2021 | 17.9% |
| TYME TECHNOLOGIES INC | 17 | Q3 2021 | 40.3% |
| ASTRAZENECA PLC | 14 | Q3 2021 | 12.9% |
| QUEST DIAGNOSTICS INC | 14 | Q3 2016 | 9.5% |
| CRYOLIFE INC | 13 | Q1 2017 | 6.6% |
| ANTARES PHARMA INC | 13 | Q3 2021 | 6.7% |
| AMARIN CORP PLC | 13 | Q3 2021 | 4.9% |
| CYTOKINETICS INC | 13 | Q3 2016 | 1.7% |
View Healthcare Value Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| NOVELION THERAPEUTICS INC. | September 20, 2019 | 1,400,000 | 7.4% |
View Healthcare Value Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2021-11-15 |
| 13F-HR | 2021-08-16 |
| 13F-HR | 2021-05-17 |
| 13F-HR | 2021-02-16 |
| 13F-HR | 2020-11-16 |
| 13F-HR | 2020-08-14 |
| 13F-HR | 2020-05-15 |
| 13F-HR | 2020-02-14 |
| 13F-HR | 2019-11-14 |
| SC 13D/A | 2019-09-20 |
View Healthcare Value Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.